IPM grows 3.9 per cent in March 2014, clocks Rs 5948 crores
10 therapies have outgrown the IPM growth and two therapies have double digit growths
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
SPDS to conduct DISSO ASIA 2014 convention in Mumbai
To promote introduction of new technology, innovation and have deliberations on various issues faced related to dissolution
IDMA to organise conference on ’Current Challenges & Opportunities in Pharma…
The theme of the conference is 'Indian Pharmaceuticals for Global Health'
Cool Chain Strategies Summit to be held in Mumbai
Will see 150+ senior level supply chain and logistics professionals
US, India face off on IP yet again
As we await the US Trade Representative's annual Special 301 Report, stakeholders on both sides of the fence seem to be hardening…
Connexios Life Sciences and Boehringer Ingelheim enter agreement
As part of the agreement, Boehringer Ingelheim obtains global rights to CNX-012, Connexios Life Sciences’ programme on AMPK…
Merck receives final antitrust clearance for AZ takeover
Chinese antitrust authority MOFCOM grants clearance
Lupin posts fourth quarter results ending March 31, 2014
Net sales grew by 17.2 per cent to Rs 110,866 million during FY 2013-14
7th international conference of SAC-ACCP held in Mumbai
The theme for this year's conference was translational research
ISCR’s theme for International Clinical Trials Day is ‘Patients First’
Requests the media to support in highlighting the impact of the current regulatory environment on patients